便

Janine Soares1,2,3, Mariana Eiras1, Dylan Ferreira1,2,4,5,6

  • 1Experimental Pathology and Therapeutics Group, Research Center of IPO Porto (CI-IPOP), RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal.

概括

这项研究确定了便中的T抗原作为结直肠癌 (CRC) 和癌前病变的潜在生物标志物. 便中的糖基化变化可能会改善非侵入性癌症检测.